Where does Endologix LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Endologix LLC ranks #7,001 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Endologix LLC hold?

Endologix LLC holds 47 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Endologix LLC's Innovation Score?

Endologix LLC has an Innovation Score of 41.0 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Endologix LLC's patent grant rate increasing or decreasing?

Endologix LLC's recent grant velocity is +53% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Endologix LLC's patents?

Endologix LLC's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Endologix LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Endologix LLC

Q: What technology areas does Endologix LLC focus on?

Endologix LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 41 patents, ranking #150 of 3,082 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Endologix ranks #7,001 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 10 technology areas.

#7,001
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 17.0
avg claims per patent: +53%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7001 · US Corporation #7,001 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,001/49,997
PHOTO-FINISH DataDirect Networks
CPC-FOCUS A61F · 10 areas
INNOV-PAR 41.0/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +53% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: DataDirect Networks, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Endologix’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (33%) Velocity 6.3 pts (15%) Breadth 11.2 pts (27%) Claim depth 10.2 pts (25%)

Qualcomm Incorporated · highest

85
Autefa Solutions… · near

41
Endologix · this assignee

41
TreeFrog Developments · near

41
Agrofresh · near

41
Gaming Arts · near

41
3D Lighting… · lowest

7

What this shows Endologix's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Endologix?

Each dot is one of Endologix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endologix’s own 17.0 claims/patent is at or below the 18.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Endologix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Endologix's grants concentrate

Endologix LLC is a focused PatentsView assignee: 10 CPC subclasses with 87.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (9 grants) versus a trough of 1 in 2018. By volume, Endologix sits between DataDirect Networks, Inc. and Grains Research AND Development Corporation.

Endologix's three-year grant acceleration

Endologix LLC shows 16 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Datadirect Networ…

47
Delta Int'l (Sing…

47
Elbit Systems OF…

47
Embarcadero

47
Fate Therapeutics

47
Flotek Chemistry

47
General Electric…

47
Grains Research A…

47
Endologix ◀

47

What this shows Endologix holds 47 patents at rank #7,001, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Endologix

By rank, the assignees closest to #7,001 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Endologix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Endologix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Endologix ranks #150 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

TreeFrog Developments, Inc. 41 Autefa Solutions Germany GMBH 41 Gaming Arts, LLC 41 Agrofresh Inc. 41

Endologix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Endologix LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.3%
2016	2	4.3%
2017	5	10.6%
2018	1	2.1%
2019	7	14.9%
2020	6	12.8%
2021	4	8.5%
2022	5	10.6%
2023	9	19.1%
2024	2	4.3%
2025partial year	4	8.5%

Which technologies does Endologix LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 41

A61B - DIAGNOSIS; SURGERY; Identification 17

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y10T - Technical Subjects Covered BY Former US Classification 2

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

C08L - Compositions OF Macromolecular Compounds 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Endologix LLC's patent record in context - here's where to go next.

Endologix LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.2% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #7,001 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Endologix LLC against DataDirect Networks, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.